13 - 16 of 167 news items
NHS England has designated Royal Brompton Hospital as the leading centre for a new national rare disease network, in collaboration with Queen’s Medical Centre, Nottingham. The two centres have developed world-leading expertise in the management of patients with cystic lung diseases. Read more
Royal Brompton and Harefield hospitals have been named as performing “better than expected” in the Care Quality Commission’s 2019 Adult Inpatient Survey. For the survey, which covers different aspects of care and treatment, the CQC looked at the experiences of more than 654 patients who stayed in our hospitals. The Trust was named better than other trusts in eight of the 11 areas covered. Read more
The pulmonary rehabilitation team at Harefield Hospital has become the first service in the country to receive full accreditation in a scheme run by the Royal College of Physicians (RCP) in association with the British Lung Foundation and the British Thoracic Society. Launched in 2018, the Pulmonary Rehabilitation Services Accreditation Scheme (PRSAS) aims to improve the quality of pulmonary rehabilitation services throughout the UK. Read more
NHS England has today announced that NHS patients in England will be some of the first people in Europe to benefit from a new treatment for cystic fibrosis (CF). Three in five patients with the genetic condition could benefit from the ‘triple combination’ treatment produced by Vertex Pharmaceuticals, called ‘Kaftrio’, or ‘Trikafta’ in the US. The treatment tackles the underlying causes of CF by helping the lungs work effectively. Read more